The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
&NA; 5‐MeO‐DMT is a natural hallucinogen acting as serotonin 5‐HT1A/5‐HT2A receptor agonist. Its ability to evoke hallucinations could be used to study the neurobiology of psychotic symptoms and to identify new treatment targets. Moreover, recent studies revealed the therapeutic potential of serotonin hallucinogens in treating mood and anxiety disorders. Our previous results in anesthetized animals show that 5‐MeO‐DMT alters cortical activity via 5‐HT1A and 5‐HT2A receptors. Here, we examined 5‐MeO‐DMT effects on oscillatory activity in prefrontal (PFC) and visual (V1) cortices, and in mediodorsal thalamus (MD) of freely‐moving wild‐type (WT) and 5‐HT2A‐R knockout (KO2A) mice. We performed local field potential multi‐recordings evaluating the power at different frequency bands and coherence between areas. We also examined the prevention of 5‐MeO‐DMT effects by the 5‐HT1A‐R antagonist WAY‐100635. 5‐MeO‐DMT affected oscillatory activity more in cortical than in thalamic areas. More marked effects were observed in delta power in V1 of KO2A mice. 5‐MeO‐DMT increased beta band coherence between all examined areas. In KO2A mice, WAY100635 prevented most of 5‐MeO‐DMT effects on oscillatory activity. The present results indicate that hallucinatory activity of 5‐MeO‐DMT is likely mediated by simultaneous alteration of prefrontal and visual activities. The prevention of these effects by WAY‐100635 in KO2A mice supports the potential usefulness of 5‐HT1A receptor antagonists to treat visual hallucinations. 5‐MeO‐DMT effects on PFC theta activity and cortico‐thalamic coherence may be related to its antidepressant activity. This article is part of the Special Issue entitled ‘Psychedelics: New Doors, Altered Perceptions’. Hightlights5‐MeO‐DMT alters cortico‐thalamic activity more in mPFC and V1 than MD thalamus.5‐MeO‐DMT augments beta band coherence between cortico‐thalamic areas.5‐HT1A‐R antagonism avoids 5‐MeO‐DMT actions in KO2A mice.Increase in PFC theta band by 5‐MeO‐DMT may be related to its antidepressant effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Meditation states and traits: EEG, ERP, and neuroimaging studies.
Cahn, B. R., & Polich, J. (2006) · Psychological Bulletin · doi:10.1037/0033-2909.132.2.180 · Cited by 1,734 · cited 1×
“, 2017) and meditation (Cahn and Polich, 2006) increase frontal theta activity.”
BackgroundCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · cited 3×
“…NMDA-R antagonist such as ketamine (Monteggia and Zarate, 2015; Zarate et al., 2006) and serotonergic hallucinogens such as psilocybin (Carhart-Harris et al., 2016a) show clinical efficacy in depressed patients resistant to other forms of treatment (Baumeister et al., 2014;…”
Grouping of brain rhythms in corticothalamic systems
Steriade, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.029 · Cited by 1,296
Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers
Gabbott, P. L. A., Warner, T. A., Jays, P. R. L., Salway, P., & Busby, S. J. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20738 · Cited by 1,227 · cited 2×
“As discussed above, coherence between mPFC and MD thalamus was the most affected coherence, probably due to the dense and reciprocal cortico-thalamic connectivity between these two areas (Gabbott et al., 2005; Groenewegen and Uylings, 2000).”
BackgroundNichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 1×
“Recently, clinical studies reported the efficacy of psilocybin for treatment-resistant depression, an effect perhaps related to activity changes of thalamic and PFC areas, as reported in fMRI studies (Carhart-Harris et al., 2012) and to themodulation in the oscillatory activity observed on EEG (Kometer et al.”
BackgroundPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 1×
“5-HT1A-R and 5-HT2A-Rs are involved in the behavioral and electrophysiological effects of hallucinogenic drugs and in the regulation of sensorimotor gating (Gonzalez-Maeso et al., 2007; Krebs-Thomson et al., 2006; van den Buuse et al., 2011; Vollenweider et al., 1998; Winter et al., 2000).”
BackgroundGonzález-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · cited 2×
“Preclinical and clinical evidence support that the psychotomimetic action of these hallucinogens is, at least, partially mediated by their agonistic actions at cortical 5-HT2A-R (Gonzalez-Maeso et al., 2007; Nichols, 2004).”
BackgroundNeural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · cited 3×
“…NMDA-R antagonist such as ketamine (Monteggia and Zarate, 2015; Zarate et al., 2006) and serotonergic hallucinogens such as psilocybin (Carhart-Harris et al., 2016a) show clinical efficacy in depressed patients resistant to other forms of treatment (Baumeister et al., 2014;…”
Cited by
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Onofrj, M., Russo, M., Delli Pizzi, S., De Gregorio, D., Inserra, A., Gobbi, G., & Sensi, S. L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02691-0 · Cited by 43
Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research · doi:10.1016/bs.pbr.2018.08.002 · Cited by 38
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Artin, H., Zisook, S., & Ramanathan, D. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i6.201 · Cited by 33
Metadata
- Authors
- Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 142
- Pages
- 219-230
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2773072410
- Cited by
- 53
- References
- 31
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.11.049
- The paper
- Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P. (2018). The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.11.049
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.